Skip to content

Impact of impaired digestive /Ama on feces and role of Chitrakadi Vati as of its correction

Association between symptoms of Ama and Purisha characteristics features and evaluation of Chitrakadi tablet as Amapachana

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052298
Enrollment
100
Registered
2023-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 to 50 years Patient having at least three symptoms of Ama i.e., Udara Gaurava (heaviness in abdomen), Mala Sanga (retention of feces/constipation)), Apakti (indigestion). Willing to participate and abide to study protocol

Exclusion criteria

Exclusion criteria: Patient below 18 years and above 50 years of age. Not willing to participate. Patient who is already on ayurveda medication especially for Pachana Chronic debilitating disease like CA, DM, T.B, CKD. Ulcerative colitis, peptic ulcer and haemorrhoids, cirrhosis of liver, portal hypertension

Design outcomes

Primary

MeasureTime frame
Subsidence generalized defecation related symptoms of AmaTimepoint: day 0 and 16th day

Secondary

MeasureTime frame
Absence of stickiness from feces The stool remains float over water (Jala Santarana) Timepoint: Day 0 and 16th day

Countries

India

Contacts

Public ContactDr D H Pandya

Institute of Teaching and Research in Ayurveda Jamnagar

darshnapandya73@gmail.com9099011095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026